comparemela.com

Latest Breaking News On - அல்லாத ப்ரிஸ்க்ரிப்ஶந் மருந்துகள் - Page 1 : comparemela.com

E-pharmacy Market Size USD 67930 Million By 2026 At A CAGR of 8 4%

E-pharmacy Market Size USD 67930 Million By 2026 At A CAGR of 8.4% - Valuates Reports BANGALORE, India, Feb. 10, 2021 /PRNewswire/ E-pharmacy Market is Segmented by Type - Over-the-counter drugs, Prescription drugs, by Application - Hospital, Clinic, by Regions & Key players Regional Growth: Global Opportunity Analysis and Industry Forecast, 2021-2026. This report is published on Valuates Reports in the Software Category. The global E-pharmacy market size is projected to reach USD 67930 Million by 2026, from USD 38400 Million in 2019, at a CAGR of 8.4% during 2021-2026. Major factors driving the growth of e-pharmacy market size are high adoption of e-commerce, increased online orders, growth in the elderly population, and rising implementation of e-prescriptions in hospitals and other healthcare services. In addition, the recent outbreak of COVID-19 has considerably influenced the utilization of online pharmacy platforms, thereby increasing the e-pharmacy market size.

FDA in 2020: COVID Vaccine and OTC Ranitidine Drugs

Wednesday, December 23, 2020 In addition to the incredible work of agency scientists and reviewers to get the first COVID-19 vaccines authorized for emergency use in December (as we covered in Part 2 of our year-end post), the Food and Drug Administration (FDA) has continued to make substantial progress on its non-COVID priorities as well. Continued Progress on Non-COVID Priorities…  Besides the obvious scientific, technical, and regulatory work that FDA and other stakeholders have been doing all year to mount a comprehensive response to the emergence of SARS-CoV-2 as a pandemic pathogen, the agency’s work on other high-priority human drug and biological product regulatory programs continued during 2020. FDA has demonstrated a fairly impressive ability to manage a huge number of competing priorities, even as certain areas like pre-approval inspections and re-inspections of facilities seeking removal from an import alert have suffered in the face of travel restrict

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.